Related Articles
Role of long noncoding RNAs in malignant disease (Review)
Splicing variants of ADAR2 and ADAR2-mediated RNA editing in glioma (Review)
Effect of eukaryotic translation initiation factor 4A3 in malignant tumors (Review)
Mechanism of alternative splicing and its regulation (Review)
Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (Review)